C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2011
12/01/2011	US20110294162 B-7 related nucleic acids and polypeptides useful for immunomodulation
12/01/2011	US20110294161 Modified Human Growth Hormone
12/01/2011	US20110294160 Cysteine Protease Autoprocessing of Fusion Proteins
12/01/2011	US20110294150 Immunoglobulin glycosylation pattern analysis
12/01/2011	US20110294146 Identification of Actinobacillus actinomycetemcomitans Antigens for Use in the Diagnosis, Treatment, and Monitoring of Periodontal Diseases
12/01/2011	US20110293760 Method for extracting substances from soapberry fruit and seed and products made therefrom
12/01/2011	US20110293667 Bioengineered Tissue Constructs and Methods for Producing and Using Thereof
12/01/2011	US20110293665 Recombinant Der P 2 Expressed in Pichia Pastoris as a "Natural-Like" Allergen for Immunotherapy and Diagnostic Purposes
12/01/2011	US20110293656 Recombinant mva capable of expressing structural hcv antigens
12/01/2011	US20110293652 Chimeric ospa genes, proteins, and methods of use thereof
12/01/2011	US20110293632 Polypeptide variants with altered effector function
12/01/2011	US20110293620 Monoclonal Antibodies For Use In Diagnosis and Therapy of Cancers and Autoimmune Disease
12/01/2011	US20110293619 CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
12/01/2011	US20110293618 Anti-human clcp1 antibody and use thereof
12/01/2011	US20110293613 Bispecific antibodies
12/01/2011	US20110293609 Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
12/01/2011	US20110293607 Antibody Variants Having Modifications In The Constant Region
12/01/2011	US20110293593 Siva 2 stabilization
12/01/2011	US20110293566 Diffocin and methods of use thereof
12/01/2011	US20110293554 Recombinant human g-csf dimer and use thereof for the treatment of neurological diseases
12/01/2011	CA2800744A1 Insulin-like growth factor 1 receptor binding peptides
12/01/2011	CA2800728A1 Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase
12/01/2011	CA2800616A1 Improved methods of screening embryonic progenitor cell lines
12/01/2011	CA2799572A1 Novel cyclic peptide compound, method for producing same, anti-infective agent, antibiotic-containing fraction, antibiotic, method for producing antibiotic, antibiotic-producing microorganism, and antibiotic produced by same
11/2011
11/30/2011	EP2390345A1 Production of molecules of interest by solid-state fermentation
11/30/2011	EP2390334A2 Expression system
11/30/2011	EP2390326A1 Process of producing human type II collagen
11/30/2011	EP2390308A1 Minicell compositions and methods
11/30/2011	EP2390269A1 Neoplasm specific antibodies and uses thereof
11/30/2011	EP2013342B1 Auto- inducible sodium phosphate symporter promoter from pichia pastoris and method for producing recombinant protein using it
11/30/2011	EP1681302B1 Angiogenesis inhibitor, production process and use thereof
11/30/2011	EP1392360B1 Modified antibodies to prostate-specific membrane antigen and uses thereof
11/30/2011	EP1329461B1 Method of eliminating human serum albumin polymers
11/30/2011	CN102264697A 生物合成产生的吡咯啉-羧基-赖氨酸以及通过吡咯啉-羧基-赖氨酸和吡咯赖氨酸残基化学衍生化的位点特异性蛋白修饰 Pyrroline biosynthesis produced - carboxy - lysine and by pyrroline - carboxy - pyrrol-lysine and lysine residues chemically derivatized site-specific protein modification
11/30/2011	CN102264379A 肌肉增强剂 Muscle enhancer
11/30/2011	CN102260728A 一种蜂王浆多肽及其用途 Polypeptides, and uses one kind of jelly
11/30/2011	CN102260727A 低分子水产胶原蛋白肽的制备方法 Preparation of low molecular weight collagen peptide Fisheries
11/30/2011	CN102260700A 玫瑰孢链霉菌基因工程菌hp-orf53-55的构建方法及其应用 Rose construction method Streptomyces sp hp-orf53-55 genetically engineered bacteria and its application
11/30/2011	CN102260689A 食品级异源分泌表达Ⅱa类细菌素的基因工程菌及其构建方法与应用 Food-grade class Ⅱa expression of heterologous secretion of bacteriocins genetically engineered bacteria and its construction method and application
11/30/2011	CN102260660A 蜂王肠道酶及其制备方法和用途 Queen intestinal enzyme and its preparation method and use
11/30/2011	CN102260585A 一种利用动物蛋白水解酶从鱿鱼内脏提取鱼油的方法 A use of animal proteolytic enzyme extracted from fish oil squid visceral way
11/30/2011	CN102260346A 一种Exendin-4类似物 One kind of Exendin-4 analogs
11/30/2011	CN102260337A 麻疯树籽粕毒蛋白的制备方法 Jatropha seed meal preparation toxin
11/30/2011	CN102260325A Antibacterial peptide NX-16, and preparation method and application thereof
11/30/2011	CN101607081B 布鲁氏菌疫苗及疫苗用抗原蛋白的制备方法 Brucella vaccines and vaccine antigen protein preparation method
11/30/2011	CN101544965B 从猪胎盘中提取多种生物活性物质的联产工艺 Extracted from pig placenta in a variety of biologically active substances cogeneration process
11/30/2011	CN101503727B 三角帆蚌酶解多肽及其制备和应用 Cumingii enzymatic peptides and their preparation and use
11/29/2011	US8067666 Model animal causing the white hair development and methods relating thereto
11/29/2011	US8067665 Methods of using human tissue factor-producing knock-in mice
11/29/2011	US8067564 Methods of obtaining a specific binding member that binds eotaxin
11/29/2011	US8067562 Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1
11/29/2011	US8067550 Hybridomas producing antibodies against non functional P2X7 receptor
11/29/2011	US8067549 Humanized antibodies and compositions for binding sphingosine-1-phosphate
11/29/2011	US8067548 Fusion proteins having mutated immunoglobulin hinge region
11/29/2011	US8067547 Stable and soluble antibodies inhibiting TNFα
11/29/2011	US8067546 Humanized anti-CD70 binding agents and uses thereof
11/29/2011	US8067247 Use of anti-CD100 antibodies for the treatment of inflammatory disorders affecting the central or peripheral nervous system
11/29/2011	US8067229 Ucp4
11/29/2011	US8067221 Von Willebrand factor (vWF)-cleaving protease
11/29/2011	US8067201 Methods for protein refolding
11/29/2011	US8067200 Fusion proteins
11/29/2011	US8067199 Anti-IL13 antibodies and uses thereof
11/29/2011	US8067197 Soluble recombinant αvβ3 adhesion receptor
11/29/2011	US8067186 Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof
11/29/2011	US8067167 Hybrid antibodies
11/29/2011	US8067157 Expression cloning in filamentous fungi
11/29/2011	US8067010 Immunological herpes simplex virus antigens and methods for use thereof
11/29/2011	US8067004 Surface antigen
11/29/2011	US8067001 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/29/2011	US8066994 Proteins comprising an IgG2 domain
11/29/2011	CA2414331C Pd-l2 molecules: novel pd-1 ligands and uses therefor
11/29/2011	CA2401438C Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
11/29/2011	CA2344764C Intein mediated peptide ligation
11/29/2011	CA2342199C Monoclonal antibodies against s100
11/24/2011	WO2011146885A2 Compositions and methods for lentiviral expression of apoa-1 or variants thereof using spliceosome mediated rna trans-splicing
11/24/2011	WO2011145744A1 Anti-human trop-2 antibody having antitumor activity in vivo
11/24/2011	WO2011145664A1 Sulfur-containing amino acid derivative
11/24/2011	WO2011145629A2 ANTIBODY CAPABLE OF BINDING TO TRANSFORMING GROWTH FACTOR ALPHA AND HAVING ANTIPROLIFERATIVE ACTIVITY ON CANCER HAVING Ras GENE MUTATION
11/24/2011	WO2011145211A1 Ketoreductase mutant
11/24/2011	WO2011123811A3 Production of post-translationally hydroxylated recombinant proteins in bacteria
11/24/2011	WO2011108809A3 Protease with improved conservation stability, and preparation method thereof
11/24/2011	WO2010129469A8 Stable high protein concentration formulations of human anti-tnf-alpha-antibodies
11/24/2011	US20110289627 Modified cry3a toxins and nucleic acid sequences coding therefor
11/24/2011	US20110288275 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/24/2011	US20110288272 Modified cry3a toxins and nucleic acid sequences coding therefor
11/24/2011	US20110288269 Design of Spacers To Increase The Expression of Recombinant Fusion Proteins
11/24/2011	US20110288034 Methods of identifying adipocyte specific genes, the genes identified, and their uses
11/24/2011	US20110288025 Biopolymer produced by fermenting the extract of soybean with folic acid and a composition containing thereof
11/24/2011	US20110288004 Viral Sequences and Uses Thereof
11/24/2011	US20110288001 Biologically active proteins activatable by peptidase
11/24/2011	US20110287971 Multi-chain eukaryotic display vectors and uses thereof
11/24/2011	US20110287486 Method for In Vitro Molecular Evolution of Protein Function
11/24/2011	US20110287485 Methods of generating libraries and uses thereof
11/24/2011	US20110287484 Expression vector containing the major envelope protein p9 of cystovirus phi6 as a fusion partner, and process for producing a membrane protein using the same
11/24/2011	US20110287483 Production of glycoproteins using manganese
11/24/2011	US20110287482 Medium for the protein-free and serum-free cultivation of cells
11/24/2011	US20110287481 Host, transformant and method for producing the transformant and method for producing o-glycosylated heterologous protein
11/24/2011	US20110287480 Neurogenin
11/24/2011	US20110287479 Protease catalyzed in situ end capping of oligopeptides in aqueous media
11/24/2011	US20110287478 Protein concentrates and isolates, and processes for the production thereof

1 ... 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 ... 1125